<--- Back to Details
First PageDocument Content
International Myeloma Foundation / Multiple myeloma / Bortezomib / Thalidomide / Millennium Pharmaceuticals / Multiple Myeloma Research Foundation / Hematopoietic stem cell transplantation / Melphalan / International Myeloma Working Group / Medicine / Cancer research / Cancer organizations
Date: 2012-04-18 11:53:10
International Myeloma Foundation
Multiple myeloma
Bortezomib
Thalidomide
Millennium Pharmaceuticals
Multiple Myeloma Research Foundation
Hematopoietic stem cell transplantation
Melphalan
International Myeloma Working Group
Medicine
Cancer research
Cancer organizations

WINTER[removed]VOLUME 5 NUMBER 9 Myeloma Today A PUBLICATION

Add to Reading List

Source URL: myeloma.org

Download Document from Source Website

File Size: 1,22 MB

Share Document on Facebook

Similar Documents

DOI:http://dx.doi.orgAPJCPBlood Groups and Risk of Cancer: a Systematic Review and Meta-Analysis RESEARCH ARTICLE ABO Blood Groups and Risk of Cancer: a Systematic Review and Meta-analysis

DocID: 1xVc0 - View Document

The annual Controlling Cancer Summit in an international academic event with plenty of opportunity for networking and debate. In an informal setting, this meeting will bring you up to date with current research and thin

DocID: 1vs04 - View Document

The annual Controlling Cancer Summit in an international academic event with plenty of opportunity for networking and debate. In an informal setting, this meeting will bring you up to date with current research and thin

DocID: 1vqre - View Document

Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT

DocID: 1voV1 - View Document

Stuttgart Research Center Systems Biology (SRCSB) Systems Biology Seminar Talk „Heterogeneity and druginduced plasticity in colorectal cancer“

DocID: 1voOg - View Document